We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Sherri N. Rohlf
Sherri N. Rohlf
Products
PRODUCTS
Maria W. Greenwald
Sherri N. Rohlf
Price:
$117.00
View
Brock A. Andersen
Sherri N. Rohlf
Price:
$117.00
View
Sant P. Chawla
Sherri N. Rohlf
Price:
$117.00
View
David R. Greeley
Sherri N. Rohlf
Price:
$117.00
View
Sujith R. Kalmadi
Sherri N. Rohlf
Price:
$117.00
View
David L. Wirta
Sherri N. Rohlf
Price:
$117.00
View
Chafic Karam
Sherri N. Rohlf
Price:
$117.00
View
Brock A. McConnehey
Sherri N. Rohlf
Price:
$117.00
View
Philip M. Bolton
Sherri N. Rohlf
Price:
$117.00
View
Roger A. Dailey
Sherri N. Rohlf
Price:
$117.00
View
View All Products by Sherri N. Rohlf
Upcoming Events
30
Nov
Medical Device Cybersecurity: Latest Regulatory Developments
05
Dec
Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing
07
Dec
Proactive Supplier Management Using Quality Agreements
13
Dec
FDA Inspection Overhaul: How Things Have Changed in 2023
14
Apr
MAGI 2024: The Clinical Research Conference
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Improper Orange Book Patent Listings Is Subject of FTC Brief in Viatris-Sanofi Dispute
Two Sweeping FDA Reorganizations Change Inspection, Review Activities
FDA Requirements for Rare Oncology Drugs Often Drug-Drug Interactions Say Scholars
Data ‘Incident’ Is Now a Breach, Henry Schein Told Customers
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
